Announcement

Collapse
No announcement yet.

One human case of Rift Valley Fever, France ex Zimbabwe - NOT

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • One human case of Rift Valley Fever, France ex Zimbabwe - NOT



    Archive Number 20111020.3132
    Published Date 20-OCT-2011
    Subject PRO/AH/EDR> Rift Valley fever, human - France: ex Zimbabwe (ME) 1st

    RIFT VALLEY FEVER, HUMAN - FRANCE: ex ZIMBABWE (MASHONALAND EAST)
    FIRST REPORT
    ************************************************** ****************************
    A ProMED-mail post
    <http://www.promedmail.org>
    ProMED-mail is a program of the
    International Society for Infectious Diseases
    <http://www.isid.org>

    Date: Wed 19 Oct 2011
    From: Guillaume Vesin <guillaume.vesin@chu-bordeaux.fr> [edited]


    A 21 year old Caucasian traveller returning from Zimbabwe, where she
    visited the rural region of Marondera [Mashonaland East province] from
    17 Jul to 11 Aug 2011, was seen in our department on 5 Sep 2011 for
    major asthenia and violent headache. She acknowledged that the next
    day after return she experienced fever that resolved within a week.

    Laboratory investigations for malaria, Lyme disease, rickettsiosis,
    dengue, chikungunya, and West Nile fever viruses were all negative
    whereas Rift Valley fever virus serology using Elisa testing was
    positive for IgM.

    On 17 Oct 2011 she is still complaining of headache although no
    relapse in fever was noted. To the best of our knowledge, this is the
    1st report of human Rift Valley fever from Zimbabwe.

    --
    Guillaume Vesin
    <guillaume.vesin@chu-bordeaux.fr>
    Dr Receveur, Pr Malvy
    Service de medecine tropicale
    CHU de Bordeaux
    France

    [ProMED-mail thanks Guillaume Vesin for forwarding this interesting
    account of the detection of the 1st known human case of Rift Valley
    fever virus (RVFV) infection in Zimbabwe.

    Rift Valley fever (RVF), a mosquitoborne zoonotic disease among humans
    and ruminants, is caused by Rift Valley fever virus, a virus belonging
    to the family _Bunyaviridae_, genus _Phlebovirus_. RVF is endemic to
    sub-Saharan African countries and has caused major outbreaks in
    several countries including Kenya, Tanzania, Somalia, South Africa,
    Madagascar, Egypt, Sudan, Mauritania, Senegal, Saudi Arabia, and
    Yemen. Pregnant ruminants infected with RVFV typically are subject to
    high-rate abortions, fetal malformation, and subclinical-to-fatal
    febrile illness, while newborn lambs usually die by acute hepatitis.
    RVFV infection in humans primarily causes a self-limiting febrile
    illness; however, some patients develop haemorrhagic fever,
    neurological disorders, or blindness after the febrile period. In
    endemic areas, _Aedes_ mosquitoes, such as _Ae. mcintoshi_ or _Ae.
    vexans_ serve as vectors, and the virus can be transmitted into
    offspring transovarially. Heavy rainfall or flooding of river banks
    due to construction of dams increases the number of permanent fresh
    water species of mosquitoes such as _Culex pipiens_, which play a role
    in amplifying RVFV among mosquitoes, ruminants, and humans (see
    Ikegami T, Makino S. The pathogenesis of Rift Valley fever. Viruses.
    2011; 3(5): 493-5;
    <http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3111045/>).

    The vast majority of human infections result from direct or indirect
    contact with the blood or organs of infected animals. The virus can be
    transmitted to humans through the handling of animal tissue during
    slaughtering or butchering, assisting with animal births, conducting
    veterinary procedures, or from the disposal of carcasses or fetuses.
    The aerosol mode of transmission has also led to infection in
    laboratory workers. There is some evidence that humans may also become
    infected with RVFV by ingesting the unpasteurized or uncooked milk of
    infected animals. To date, no human-to-human transmission of RVF has
    been documented, and no transmission of RVF to health care workers has
    been reported when standard infection control precautions have been
    put in place (see
    <http://www.who.int/mediacentre/factsheets/fs207/en/index.html>).

    Although the human case described above may be the 1st record of human
    infection in Zimbabwe, phylogenetic analyses of RVF viruses isolated
    in Zimbabwe has revealed the presence of multiple virus lineages
    indicating that the spread of distinct RVF virus genotypes is an
    ongoing process and can occur over large geographic distances (see
    Bird, et al. J Virol. 2007 March; 81(6): 2805-16;
    <http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1865992>).

    Marondera is a town and district in Mashonaland East, Zimbabwe,
    situated about 72 km (45 mi) east of the capital Harare. It can be
    located in the HealthMap/ProMED-mail interactive map of Zimbabwe at
    <http://healthmap.org/r/1m1w>. - Mod.CP]

  • #2
    Re: One human case of Rift Valley Fever, France ex Zimbabwe



    A case of fever Rift Valley (RVF) was reported in France, Bordeaux University Hospital.

    This is a woman of 21, who traveled to Marondera (Mashonaland East province, northeast of the country) between July and August 2011 and on his return with a high fatigue and headache.

    RVF is endemic and epidemic in several countries in Southern Africa and East (Note RVF). In 2010, an outbreak of RVF has been reported in South Africa (at least 221 cases and 23 deaths), Botswana and Namibia.

    Epizootics have been reported in Zimbabwe and the recent outbreaks reported from 2001, 2009 and 2010 without any real figures (OIE).

    This case would be the first human cases of RVF reported in Zimbabwe.

    Comment


    • #3
      Re: One human case of Rift Valley Fever, France ex Zimbabwe - NOT

      ProMED: Your 24/7 early warning system for emerging infectious diseases worldwide. Subscribe now to search alerts.


      Published Date: 2011-11-29 21:06:58
      Subject: PRO/AH/EDR> Rift Valley fever, human - France (02): ex Zimbabwe (ME) NOT
      Archive Number: 20111129.3486

      RIFT VALLEY FEVER, HUMAN - FRANCE (02): ex ZIMBABWE (MASHONALAND EAST)
      NOT
      ************************************************** ************************

      A ProMED-mail post
      ProMED: Your 24/7 early warning system for emerging infectious diseases worldwide. Subscribe now to search alerts.

      ProMED-mail is a program of the
      International Society for Infectious Diseases
      The International Society for Infectious Diseases advances research, education, and global outbreak response worldwide.


      Date: Tue 29 Nov 2011From: Marc Grandadam [edited]


      Rift Valley Fever, France ex Zimbabwe: not confirmed
      ----------------------------------------------------
      On Thu 20 Oct 2011, a case of Rift Valley fever (RVF) imported into
      France from Zimbabwe was reported by ProMED-mail (Rift Valley fever,
      human - France: ex Zimbabwe (ME) 1st Archive Number: 20111020.3132).
      As reporting of RVF is mandatory in France, the patient's samples were
      sent to the National Reference Laboratory for Arboviruses for
      confirmation.

      The 1st serum, obtained at day 25 after symptom onset was
      reinvestigated for the presence of anti-arbovirus antibodies (i.e.,
      Dengue; Chikungunya; West Nile; Rift Valley fever). Only a borderline
      IgM reactivity against RVF virus antigen was detected. A 2nd sample
      obtained at day 67 after onset was found negative for both IgM and IgG
      for all antigens tested. The lack of enhancement of IgM response and
      no IgG seroconversion led us to conclude that the transient IgM
      response in the initial sample was a non-specific reaction.
      Consequently RVF infection has been classifies as 'not confirmed.'

      Diagnosis of imported cases has proven to be valuable for the global
      surveillance of arboviruses. Thus, clinicians should be aware that
      pathologies (case definition; diagnostic procedures including
      interpretation criteria), especially where mandatory reporting at the
      national or the international levels, is required.

      --
      Dr Marc Grandadam
      National Reference Centre for Arboviruses
      Institut Pasteur
      Paris
      France

      and
      Dr Deny Malvy
      Service de Medicine Tropicale
      CHU de Bordeaux
      France

      [ProMED-mail thanks Drs Grandadam and Malvy for providing this
      information and correcting the record. - Mod.CP
      ]

      Comment

      Working...
      X